The Niva Bupa Health Insurance IPO has been making waves, attracting strong interest from investors. If you’re looking to invest in this IPO or just want to stay informed, here’s a complete breakdown of everything you need to know.
Niva Bupa Health Insurance IPO Subscription Status
The Niva Bupa Health Insurance IPO has closed its subscription process on November 11, and it received a solid response. By 10:24 AM on the last day of bidding, the IPO was 1.25 times subscribed, with 21,54,61,200 shares bid against the 17,28,57,143 shares on offer.
- Qualified Institutional Buyers (QIBs): 1.5 times subscribed
- Retail Individual Investors (RIIs): 1.68 times subscribed
- Non-Institutional Investors (NIIs): 0.44 times subscribed
The price band for the IPO was Rs 70-74 per share, and it was open for subscription from November 7-11.
Niva Bupa Health Insurance IPO GMP (Grey Market Premium)
As of today, the grey market premium (GMP) for the Niva Bupa Health Insurance IPO is Rs 3. This means that investors expect a 4.05% listing gain when the shares are listed on the stock exchanges. The GMP fluctuates based on market sentiments, so keep an eye on it before the listing date.
IPO Issue Details
- Total IPO Size: Rs 2,200 crore
- Fresh Issuance: Rs 800 crore
- Offer-for-Sale (OFS): Rs 1,400 crore
- Price Band: Rs 70 to Rs 74 per share
The proceeds from the IPO will be used to expand the company’s business operations. The company had already raised Rs 990 crore from anchor investors prior to the public subscription.
Key Dates for Niva Bupa Health Insurance IPO
- IPO Open Date: November 7, 2024
- IPO Close Date: November 11, 2024
- Allotment Date: November 12, 2024
- Refunds: November 12, 2024
- Shares Credit to Demat Accounts: November 14, 2024
- Listing Date: November 14, 2024
About Niva Bupa Health Insurance
Niva Bupa Health Insurance is one of India’s leading health insurance companies, offering a wide range of health plans. With a 17.29% market share in the Indian standalone health insurer (SAHI) market for fiscal 2025, the company has been growing rapidly, especially with its gross direct premium income (GDPI) of Rs 5,494 crore for fiscal 2024.
In terms of profits, Niva Bupa recorded a net profit of Rs 81.85 crore for fiscal 2023-24, a significant jump from the previous year. However, its operating profit declined to Rs 188 crore, down from Rs 350.9 crore in the previous year.
Peer Comparison
Niva Bupa competes with other big players in the health insurance space, including:
- Star Health & Allied Insurance: EPS of Rs 14.48, PE ratio of 36.97, RoNW of 14.35%
- ICICI Lombard General Insurance: EPS of Rs 39.03, PE ratio of 45.92, RoNW of 17.17%
- New India Assurance: EPS of Rs 6.77, PE ratio of 35.23, RoNW of 5.13%
Why Invest in Niva Bupa Health Insurance IPO?
The Niva Bupa Health Insurance IPO offers investors a chance to invest in a leading player in the growing Indian health insurance market. The company is expanding its market share and has shown impressive growth in its financials. With a solid business model and strong backing from prominent investors, Niva Bupa presents an attractive investment opportunity.
FAQs
- What is the subscription status of Niva Bupa Health Insurance IPO?
The Niva Bupa Health Insurance IPO is 1.25 times subscribed as of the final day of bidding. - What is the grey market premium (GMP) for the Niva Bupa IPO?
The GMP for the IPO is Rs 3, indicating a potential 4.05% listing gain. - When will the Niva Bupa Health Insurance IPO be listed?
The IPO is scheduled to be listed on November 14, 2024. - How can I check the Niva Bupa IPO allotment status?
You can check the allotment status by visiting the KFin Technologies website or logging into your Demat account. - What is the price band of Niva Bupa Health Insurance IPO?
The price band for the IPO is Rs 70 to Rs 74 per share.
This post is for informational purposes only.Invest responsibly.No guarantees of results. Seek professional guidance before investing.Consult experts for personalized advice.AI-assisted content, editorially reviewed.See our terms for details. Follows Google policies.Not affiliated with Investopedia.com. investopedia.co.in Independent site.
